Jim Cramer Broke Down 16 Stocks Including Pharma Plays for Rising Oil
In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil.
Hinge Health Inc. (HNGE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BIT Capital GmbH Jan Beckers | 3,316,101 | $154,032,891 | +80% | 5.67% |
| 2. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 1,805,751 | $83,877,134 | +228% | 0.28% |
| 3. | Millennium Management Israel Englander | 1,479,642 | $68,729,371 | +193% | 0.03% |
| 4. | Braidwell LP Alex Karnal | 1,304,623 | $60,599,738 | +44% | 1.94% |
| 5. | Alyeska Investment Group Anand Parekh | 1,226,972 | $56,992,849 | -6% | 0.16% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.02 | 668 | $26,063.16 | 0 | 2026-04-01 | Filing | |
| $38.45 | 49,332 | $1,896,716.74 | 668 | 2026-04-01 | Filing | |
| $42.80 | 672 | $28,763.15 | 401,427 | 2026-03-23 | Filing | |
| $42.45 | 8,346 | $354,299.38 | 402,099 | 2026-03-23 | Filing | |
| $41.29 | 1,988 | $82,076.17 | 410,445 | 2026-03-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,274 | $395,446 | 0% | |
| 2. | 1,000 | $38,560 | 0.04% | |
| 3. | 300 | $11,568 | 0% | |
| 4. | 17 | $656 | 0% |
News See All
Hinge Health, Inc. (HNGE) Delivers Strong Q4 Results and Optimistic 2026 Guidance, Truist Reaffirms Buy Rating
Hinge Health, Inc. (NYSE:HNGE) ranks among the most shorted stocks to buy according to analysts.
11 Most Shorted Stocks to Buy According to Analysts
Although holes are starting to form, the stock market doesn't seem to be in danger of crashing just yet, with the S&P 500 down only 1% from its record high.
Jim Cramer Put These 16 Stocks Under the Microscope
Jim Cramer, the host of Mad Money, said on Thursday that the market’s sharp move had little to do with fundamentals and everything to do with a massive shift out of hardware stocks like NVIDIA and into...
KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating
That same day, Evercore ISI analyst Elizabeth Anderson lowered the price target to $50 from $65 while keeping an Outperform rating.
Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares
TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares.
15 Innovative Healthcare Stocks to Buy According to Analysts
Over the last two years, artificial intelligence has propelled global financial markets into a boom, with stocks reaching all-time highs.
Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes
Hinge Health extended its winning streak to a third consecutive day on Wednesday, surging 17.28 percent to close at $38.76 apiece as investors took heart from strong revenue performance last year, bolstering...
Hinge Health, Inc. (NYSE:HNGE) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining us, welcome to the Hinge Health Fourth Quarter 2025 Earnings Call. After today's prepared remarks, we will host a question and answer session.
Hedge Fund Resource Center